As shown in the stained images, the four PR-DE-ERSGs (F2R, HEY2, PXDN, and RNF19A) exhibited differences in protein expression levels between glioma and normal brain tissues, consistent with their differential expression results based on the TCGA dataset (Figures 5(l)–5(o)). This evidence concerns the gene RNF19A and central nervous system cancer.